Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
197.59
-0.62 (-0.31%)
Sep 18, 2024, 4:00 PM EDT - Market closed
Biogen Stock Forecast
Stock Price Forecast
The 23 analysts with 12-month price forecasts for Biogen stock have an average target of 278.13, with a low estimate of 190 and a high estimate of 373. The average target predicts an increase of 40.76% from the current stock price of 197.59.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Biogen stock from 23 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '24 | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 7 | 7 | 7 | 7 | 7 |
| Buy | 9 | 9 | 9 | 8 | 10 | 10 |
| Hold | 7 | 7 | 7 | 7 | 6 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 25 | 23 | 23 | 22 | 23 | 23 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $292 | Buy | Reiterates | $292 | +47.78% | Sep 9, 2024 |
| Needham | Needham | Strong Buy Reiterates $285 | Strong Buy | Reiterates | $285 | +44.24% | Sep 4, 2024 |
| Needham | Needham | Strong Buy Reiterates $285 | Strong Buy | Reiterates | $285 | +44.24% | Aug 19, 2024 |
| Mizuho | Mizuho | Buy Maintains $277 → $251 | Buy | Maintains | $277 → $251 | +27.03% | Aug 6, 2024 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $340 → $302 | Strong Buy | Reiterates | $340 → $302 | +52.84% | Aug 5, 2024 |
Financial Forecast
Revenue This Year
9.83B
from 9.84B
Decreased by -0.06%
Revenue Next Year
9.76B
from 9.83B
Decreased by -0.75%
EPS This Year
16.47
from 7.97
Increased by 106.64%
EPS Next Year
17.48
from 16.47
Increased by 6.11%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 10.4B | 10.9B | 11.2B | ||
| Avg | 9.8B | 9.8B | 10.0B | ||
| Low | 9.2B | 8.7B | 8.7B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 6.0% | 10.4% | 15.1% | ||
| Avg | -0.1% | -0.8% | 2.4% | ||
| Low | -6.3% | -11.4% | -11.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 17.57 | 21.00 | 23.16 | ||
| Avg | 16.47 | 17.48 | 18.72 | ||
| Low | 15.60 | 14.14 | 14.94 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 120.4% | 27.5% | 32.5% | ||
| Avg | 106.6% | 6.1% | 7.1% | ||
| Low | 95.8% | -14.1% | -14.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.